Log In
Print
BCIQ
Print
Print this Print this
 

PXL-01, PXL01

  Manage Alerts
Collapse Summary General Information
Company Pergamum AB
DescriptionSynthetic peptide derived from human lactoferrin and combined with sodium hyaluronate
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationAdhesions
Indication DetailsPrevent post-surgical adhesions; Prevent post-surgical adhesions in patients undergoing flexor tendon repair surgery
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today